Pathology and Molecular Biology of Melanoma
- PMID: 37504268
- PMCID: PMC10377842
- DOI: 10.3390/cimb45070352
Pathology and Molecular Biology of Melanoma
Abstract
Almost every death in young patients with an advanced skin tumor is caused by melanoma. Today, with the help of modern treatments, these patients survive longer or can even achieve a cure. Advanced stage melanoma is frequently related with poor prognosis and physicians still find this disease difficult to manage due to the absence of a lasting response to initial treatment regimens and the lack of randomized clinical trials in post immunotherapy/targeted molecular therapy settings. New therapeutic targets are emerging from preclinical data on the genetic profile of melanocytes and from the identification of molecular factors involved in the pathogenesis of malignant transformation. In the current paper, we present the diagnostic challenges, molecular biology and genetics of malignant melanoma, as well as the current therapeutic options for patients with this diagnosis.
Keywords: clinical implications; genetics; melanoma; molecular biology.
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Matthews N.H., Li W.Q., Qureshi A.A., Weinstock M.A., Cho E. Epidemiology of Melanoma. In: Ward W.H., Farma J.M., editors. Cutaneous Melanoma: Etiology and Therapy. Codon Publications; Brisbane, AU, Australia: 2017. [(accessed on 5 May 2023)]. Chapter 1. Available online: https://www.ncbi.nlm.nih.gov/books/NBK481862/ - DOI - PubMed
-
- Hall H., Miller D.R., Rogers J.D., Bewerse B. Update on the incidence and mortality from melanoma in the United States. [(accessed on 5 May 2023)];J. Am. Acad. Dermatol. 1999 40:35–42. doi: 10.1016/S0190-9622(99)70562-1. Available online: https://www.sciencedirect.com/science/article/pii/S0190962299705621. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
